Introduction Early biomarker discovery studies have praised the value of their emerging
results, predicting an unprecedented impact on health care. Biomarkers are expected to …

The diagnosis of Duchenne and Becker muscular dystrophy (DBMD) is made by genetic
testing in approximately 95% of cases. Although specific mutations can be associated with …

Duchenne muscular dystrophy (DMD) is a severe genetic disorder characterized by the lack
of functional dystrophin. DMD is associated with progressive dilated cardiomyopathy …

Background Cardiovascular disease is the leading cause of death in patients with
Duchenne muscular dystrophy (DMD)—a fatal X-linked genetic disorder. Late gadolinium …

Background The known impairments of the cardiovascular system in Parkinson´ s disease
(PD) are caused by autonomic dysfunction and manifested mainly in postural hypotension …

Background Duchenne muscular dystrophy (DMD) manifests in males mainly by skeletal
muscle impairment, but also by cardiac dysfunction. The assessment of the early phases of …

Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder leading to progressive
skeletal and cardiac myopathy. Elevated myocardial T1 values correlate with fibrosis in most …

Background Progressive cardiomyopathy accounts for almost all mortality among Duchenne
muscular dystrophy (DMD) patients. ‍ Thus, our aim was to comprehensively characterize …

In this prospective study involving 37 Duchenne muscular dystrophy (DMD) patients aged 8–
18 years and older, we examined the impact of neurological and cardiac factors on quality of …

Rest pulmonary circulation parameters such as pulmonary transit time (PTT), heart rate
corrected PTT (PTTc) and pulmonary transit beats (PTB) can be evaluated using several …